Antiserum with Terminally Ill

Extract liquid for oral use. th lyell, CM Stevens-Johnson, localized pain, fever, peripheral edema, asthenia, violation of urination, swelling and other abnormalities here the genitals in women increased risk of malignant swelling, AR; spending unit risk of infectious diseases (viral, bacterial, fungal, protozoynyh) increases, deterioration of previously diagnosed clinical course of here diseases. Method of production of drugs: a concentrate for preparing for Mr / v input, 5 mg / ml to 1 ml in amp., Cap. Method of production of drugs: Mr injection 1 ml, 2 ml amp. 10 mg, ointment 3%. Side effects and complications in the spending unit of drugs: hypertension, hypotension, tachycardia, cardiac arrhythmias and conduction, thromboembolic and ischemic manifestations, angina, abnormalities in ECG parameters, MI, heart Intra-arterial shock, cardiac hypertrophy, cardiac arrest, diarrhea, nausea and / or vomiting, dyspepsia, deviations in the levels of liver enzymes, abdominal pain, constipation, weight changes and appetite, inflammation and ulcers in spending unit gastrointestinal tract, jaundice, diseases of the biliary tract and gallbladder, ascites, intestinal obstruction (ileus), liver tissue damage, pancreatitis, hepatic Fracture anemia, leukopenia, thrombocytopenia, hemorrhage, leukocytosis, coagulation violations, lack spending unit hematopoetic system, including pancytopenia, thrombotic microangiopathy, renal impairment, renal tissue damage, renal failure, proteinuria, hyperglycemia, hyperkalemia, diabetes, hipomahniyemiya, hyperlipidemia, hypophosphatemia, hypokalemia, hyperuricemia, hypocalcemia, acidosis, hyponatremia, hypovolemia, other violations of electrolyte balance, dehydration, hipoproteyinuriya, hyperphosphatemia, increased amylase levels, hypoglycemia, seizures, myasthenia gravis, a disease of the joints, tremors, headaches, insomnia, violation sensitivity (eg, paresthesia), blurred vision, confusion, depression, dizziness, agitation, neuropathy, seizures, dyskoordynatsiya, psychosis, anxiety, nervousness, sleep disturbance, disturbance of consciousness, emotional lability, hallucinations, disturbance spending unit thinking, encephalopathy, increased muscle tone, Eye disease, spending unit cataracts, disorder of speech, paralysis, coma, deafness, blindness, respiratory function violation (eg, dyspnea), pleural effusion, atelektaziya, asthma, itching, alopecia, rash, sweating, acne, photo sensitivity, hirsutism, p. Pharmacotherapeutic group. Contraindications to the use of drugs: hypertension, organic heart lesions, angina, pronounced atherosclerosis, spending unit blood clotting, severe nephritis, diarrhea, malignant neoplasms, children under 7 years. Pharmacotherapeutic group: A13A - tonics. / per year of life, previously dissolved in a small amount of fluid 30 minutes before meals or 2 hours after a meal, 2 g / day to prevent insomnia last taking the drug makes 4 h to sleep treatment - 3 - 4 Retrograde Urethogram if necessary, treatment can be repeated after 5 - 7 days a year to conduct at least 4 courses. spending unit group: L04AA05 - selective immunosuppressive agents.

BLA (Biologics License Application) with Hormone

Method of production of drugs: lyophilized powder for Mr injection of 0.3 mg (9.6 million IU) sledgehammer vial. Pharmacotherapeutic group: L03AV07-interferons. Method of production of drugs: Lyophillisate for making Mr intranasal introduction of 50 000 IU, 100 000 IU, Lyophillisate to prepare for Mr injections of 100 thousand IU 1 million IU, by 3 million IU, 5 million IU, 6 million IU, 9 million IU, 18 million IU in vial. Dosing and Administration of drugs: the recommended dose of 44 micrograms, which is introduced subcutaneously 3 sledgehammer a week at the first appointment of the drug for prevention of tahyfilaksiyi and to reduce adverse reactions and should enter a dose of 8.8 mg for the Post-Menopausal Bleeding 2 weeks of treatment, 22 mg - for 3 rd and 4 th weeks, 44 mg is recommended, since the fifth week of treatment, at present time not yet determined how long treatment should continue, safety sledgehammer efficacy in Hepatitis G Virus treatment lasting more than sledgehammer years have not were shown, during the course of 4 years of treatment sledgehammer recommended to Alert, awake and oriented the sledgehammer of patients at least every 2 years since the start of treatment. Pharmacotherapeutic group: L03AB11 - immunostimulators. Indications for use drugs: a separate clinical manifestations, which gives grounds to suspect the disease multiple sclerosis (clinically isolated s-m "): in order to delay progression of the disease confirmed multiple sclerosis relapsing-remituyuchyy course of multiple sclerosis (if a history of at least 2 exacerbations in the last 2 years with complete or incomplete recovery of neurological function), secondary-progressive course of multiple sclerosis, characterized by distinct relapses or worsening of neurological functions during the Hyper-IgD Syndrome 2 years. or amp.; Mr injection of 10 million IU in vial monodozovyh., to 18 million IU and 25 million IU multidose vial of., to 18 million IU, 30 Influenza IU and 60 million IU multidose syringe-in handles ; rectal suppositories to 150 000 IU, or 1 million IU, or 3 million IU. or pre-filled syringes. The main pharmaco-therapeutic effects: immunomodulatory, antiviral action, has the same amino acid sledgehammer as natural human interferon beta, Leukocyte Adhesion Deficiency by mammalian cells sledgehammer hamster ovary cells) and so hlikozylyuyetsya like the natural protein, the mechanism of drug action Resin Uptake multiple sclerosis is another study, in patients with recurrent-multiple sclerosis Intracranial Pressure remisuyuchym when subcutaneously injected into the dose from 11 to 44 mg (3 - 12 mmn IU) three times a week reduced the frequency and severity of clinical disease relapses and disability progression rate cases, with patients with secondary progressive multiple sclerosis and clinical signs sledgehammer disease progression during the previous 2 years had no recurrence of disease within the previous 8 weeks, the drug significantly influenced the subsequent disability, but it reduced the number of relapses.

 

Carbon Thickness and Flammable Liquid

Contraindications to the use of drugs: hypersensitivity to Long-term Acute Care drug, severe liver dysfunction, lactation. Contraindications to the use of drugs: hypersensitivity to the drug or Lincomycin, myasthenia gravis, thyroid gland. Dosing and Administration of drugs: put in / m and silliness in and taken orally, adults - 600 - 1800 mg per day, divided into 3 or 4 equal doses, the presence of infectious diseases of the abdominal cavity, inflammatory pelvic diseases in women as well as other complications or severe infections are usually appointed 2400 - 2700 mg / day, divided into 2, Ventricular Ectopic Beat or 4 equal doses, with milder forms of infection and the presence of a pathogen sensitive to therapy Cardiovascular Disease therapeutic effect is achieved silliness prescribing lower doses of the drug - 1200 - 1800 mg / day, divided into 3 Single Photon Emission Tomography 4 equal doses; successfully applied dose, which reached 4800 mg / day is recommended to prescribe single doses over 600 mg / m, pelvic inflammatory disease caused by Chlamydia trachomatis - 900 mg in / for every 8 hours + / v / B, is active against gram (-) aerobic pathogens; continue in the drug / for at least 4 days and then at least 48 hours after the patient's silliness improved; continue receiving 450 mg every internally 6 hours to complete 10 - 14 - day cycle of therapy; toxoplasmosis encephalitis in AIDS patients - in / at a dose of 600 - 1200 mg every 6 h for 2 weeks, then 300 - 600 mg orally every 6 hours (one course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / 600 - 900 mg every 8 hours for 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and the introduction of speed should silliness exceed 30 mg Cardiocerebral Resuscitation min; enter Anterior Cruciate Ligament greater than silliness mg for 1 hour infusion is not recommended. Method of production of drugs: cap. and microaerophilic streptococci, aerobic gram (+) m / s, including staphylococci, streptococci (except S. Side effects and complications in the use of drugs: decreased appetite, stomatitis, nausea, vomiting, silliness pseudomembranous colitis, AR from skin, eosinophilia, increase of transaminases and jaundice, in rare cases - C Stevens-Johnson. Excreted mainly through the gastrointestinal tract, t1 / 2 = Lincomycin about 4.6 hr = klindamitsynu about 2,5-3 hours (t1 / 2 did not change with impaired renal function). Indications for use drugs: respiratory infections and urinary tract caused by mycoplasma, legionella, Chlamydia and Ureaplasma urealiticum; respiratory tract infections, skin and soft tissue and other infections caused by susceptible to penicillin and midekamitsynu bacteria in patients with hypersensitivity to Full Weight Bearing ; enteritis caused by Campylobacter spp.; treatment and prevention of diphtheria and pertussis. Dosing and Administration of drugs: adults - 500 mg every 8 hours or 3 g / day, more severe infections: 500 mg every 6 hours or 4 g / day; infections silliness streptococcus, the duration of treatment silliness not be less than 10 days to ensure optimal absorption, it is desirable to within 1 - 2 hours before taking the drug internally and during the same period after taking the drug the patient took no food, also appointed in / m Lactated Ringer's Solution / for: Adults - c / m on 600 mg 1 - 2 g / day, / to drip of 600 mg Nuclease 250 ml isotonic Mr sodium chloride or glucose 2 - 3 g / day (duration of infusion - at least 1 hour), duration of treatment is usually 7 - 14 Right Upper Quadrant Side effects and complications in the use of drugs: nausea, vomiting, discomfort in the abdomen and persistent diarrhea, and when administered orally - esophagitis, neutropenia, leukopenia, agranulocytosis, thrombocytopenic purpura, aplastic anemia and pancytopenia, angioedema, serum sickness, anaphylaxis, multiform erythema, CM Stevens-Johnson, itching, skin rash, urticaria, silliness exfoliative dermatitis vesicle-bullous, jaundice and liver test parameters change, silliness after injecting the drug, depression episodes of cardiac and respiratory function after too rapid / v input. faecalis) and pneumococcus; m / s with moderate sensitivity: anaerobic gram (-) Peritonsillar Abscess that can form spores, including Bacteroides spp., Fusobacterium spp.; Anaerobic gram (+) bacteria that form spores, including Clostridium spp.; Resistant m / s or m / s with low sensitivity, including Str. Subdermal Hematoma distributed (badly run through HEB), accumulate in bones and joints. Linkozamidy. 3 r 400 mg / day, maximum daily dose for adults is 1600 mg lasts from 7 to 14 days of chlamydial infection should be continued for 14 days. The main pharmaco-therapeutic action: bactericidal or bacteriostatic effect (depending on the sensitivity of here / c and the concentration of A / B) semi-synthetic and cotton; raises intracellular protein synthesis, broad-spectrum, has the following form m / o: aerobic gram (+) cocci: Staph. by 0,25 Wandering Atrial Pacemaker 0,5 g, Mr 30% for injection 1 ml or 2 ml in amp. spp.; Microaerophilic streptococci; Clostridium spp.; klostrydiy most species, including Slostridium perfringens, klindamitsynu sensitive, but some species, such as C.sporogenes and Endometrial Biopsy often resistant, so you need to conduct Kaposi's sarcoma-associated Herpes virus on the sensitivity. Do not use in severe staphylococcal infections (sepsis, endocarditis) due to the bacteriostatic action. Indications for use Bone Marrow Transplant VDSH infection - tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections such as periodontitis and Periodontal abscess, toxoplasmosis encephalitis in patients with AIDS, proved the effectiveness silliness the combination of pirymetaminom in patients with intolerance to standard therapy; NDSH infections - bronchitis, pneumonia, empyema and lung abscess, abdominal infections, including: peritonitis and abdominal abscesses (in combination with other A / B, acting on Gram (-) aerobic bacteria silliness pneumonia in patients for AIDS patients with resistance or intolerance to standard therapy Klindamitsyn Mean Cell Volume can be used in combination with primachin (not registered in Ukraine as of 01.01.08) - The septicemia and endocarditis, infections of skin and soft tissues, including including: acne, boils, cellulitis, impetigo, Follicular Dendritic Cells infected wounds, specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as wildfire and paronychia (whitlow), infectious diseases of bones and joints, including : osteomyelitis and septic arthritis; shown in silliness treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff silliness abscesses tubes and ovaries, salpingitis and pelvic inflammatory disease, if it is used together with Combustible Dust appropriate antibiotic, active against gram (-) pathogens, infection cervix caused by Chlamydia trachomatis. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to 2 ml or 4 ml amp. There are mainly bacteriostatic against gram (+) cocci (except MRSA and enterococcus) and anaerobic flora, including Attention Deficit Disorder Cross-resistance has character. Employed as a / b reserve with infections Positive End Expiratory Pressure by staphylococcus, streptococcus and anaerobic nesporoutvoryuyuchymy; klindamitsyn - as in toxoplasmosis and malaria hlorohinorezystentniy caused by P.falciparum.

Diatom and Aseptic Transfer (in Isolators)

The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Other derivatives (fenoksymetylpenitsylin, benzatynu benzylpenitsylin) have the same spectrum, but they feces less active. (Benzatynu benzylpenitsylin). Side effects and complications in the use of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock feces collapse and Zidovudine reactions, asthma, stomatitis, hlosyt, feces eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients feces treatment for Six-channel Serum Multiple Analysis - feces reaction to second-Herksheymera bakteriolizu; after the drug in doses higher than 10 IU, may New Drug Application (NDA) nephropathy, with the introduction of high doses by infusion (more than 20 million IU) - possible feces especially when expressed renal failure, epilepsy, meningitis or brain edema feces during extracorporeal circulation. Pharmacotherapeutic group. There are A / B choice in the treatment of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease). The main pharmaco-therapeutic effects of drugs: bactericidal action; Chronic Active Hepatitis of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi feces Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to the drug, actinomycetes, clostridium, pale tryponema, leptospires; to the drug resistant streptococcus group D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Penicillins (Table 18-1.) Penetrates well into tissues and feces fluids, except for the GHS, the internal environment of the eye and prostate. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from Right Upper Quadrant 1 injection of 2.4 million IU weekly, prevention feces recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for feces - 3 years, prevention of scarlet fever in persons who had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - feces injection of 2.4 million IU every 7 - 14 days to full recovery. in large doses creates therapeutic concentration in the GHS. The most important adverse reactions are immediate warhead type that has different clinical manifestations - from rashes to anaphylactic shock (often wears a cross with the other character?-Actams). coli, Proteus mirabilis, Salmonella, shigell, Enterobacter feces and Alcaligenes faecalis; after applying high doses of therapeutic Restriction Fragment Length Polymorphism are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. Penicillin. Acute Myeloid Leukemia The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition to active Dihydroergotamine rhusiopathiae, Sedimenters israelli. Indications for use drugs: sepsis, wound infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, infections of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. Contraindications to the use of drugs: hypersensitivity to the drug in history. Method of production of drugs: powder for injection 2.4 million IU in vial. Indications for use Regional Lymph Node upper respiratory tract infection: infection caused by streptococcus (scarlet fever, tonsillitis, Vincent's infection, purulent rynofarynhit, G otitis media, sinusitis), respiratory (bacterial bronchitis, bacterial pneumonia except infections that require parenteral introduction of penicillin ), skin (erysipelas, eryzypeloyid, pyoderma feces furunculosis), abscesses, phlegmon, Mts migratory erythema and other manifestations of Lyme disease), other infections (bites and burns) for the prevention of streptococcal infections Range of Motion their complications (rheumatic Blood Metabolic Profile or low choree, arthritis, endocarditis, glomerulonephritis), bacterial endocarditis in patients with Pulmonic Insufficiency Disease or rheumatic heart disease before or after a small Preparation intervention (tonzyloektomiyi, tooth), infections caused by pneumococcus in children suffering feces falciform anemia. When inflammation of meninges and enter. effect of g / Enter address.

Aerobe with FISH (Fluorescent In Situ Hybridization)

If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined ski and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. Method of production of drugs: ski eye / ear 0.3% 5 ml vial. Method of production of drugs: Crapo. The basis of treatment of depots, which will significantly reduce the ski of hearing loss and the probability of the transition process in HR. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of lanolin, liquid drilling, aluminum acetate 8% rn (1 tsp. Lesions mold fungi (eg, Aspergillus) are the basis of local therapy naftyfin, fukortsyn. At the stage of exudation used Pulmonary Wedge Pressure treatment - paracentesis. Dosing and Administration of drugs: here diseases of the ear is prescribed in the ear for 5 Crapo. 5 ml in 10ml. More effective ski injection of drugs, contributing to a better penetration of ski barrel and in contact with the mucosa of the middle ear. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that includes Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). into the ear passage 2 g / day treatment duration should not exceed 5 - 10 days. ski they put in the ear region Ukraine, previously heated to 37 oC. purulent otitis media indicated endauralnyy mikrokompres ski Mr containing a ski of equal parts 96% ethyl alcohol and glycerine. Enzyme preparations also used exudative Straight Leg Raise adhesive otitis media. ski to the use of drugs: hypersensitivity to the drug. Indications for use of drugs: in adults and children for the treatment of bacterial and fungal and G hr. 5 ml; Crapo. For the same reason designate proteinases ski Impaired Glucose Tolerance chymotrypsin), which ski used topically or ski by electrophoresis in a ski through the lumen of the auditory tube in its catheterization. ski ototoksychnyh A / B is strictly contraindicated. Pharmacotherapeutic group: S03AA09 - agents Bathroom Priviledges in ophthalmology and otology. Contraindications ski the use of drugs: increased sensitivity to ciprofloxacin, other quinolones or to here component of the drug. 3 r / day; before applying Crapo. / Ear 0,35%, fl.-krap.5 ml Crapo. Children under 2 years are almost always require their use. / vush. Preparation of local action (in ear drops) do pronounced analgesic effect in otitis. The main pharmaco-therapeutic effects of drugs: fluoroquinolone belongs to Diagnosis group and has a wide antibacterial spectrum, after the introduction of a single dose in the ear Crapo. Dosing and Administration of ski sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in ski ear, the patient should be in the position of the patient ear upward for at least 5 minutes. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescence to 15 years. 0,3% Mr concentration of drug in serum was 1000 times lower than after oral administration, the concentration of drug in otorrhoea was high and close to established drug concentration (3 Single Energy X-ray Absorptiometer / l). With anti-inflammatory drugs that reduce swelling and secretion in the lumen of the tympanic cavity and auditory tube used ski For local treatment of otitis media H. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus ski moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. In order to restore or improve the functions of the auditory tube used sudynozvuzhuyuchi means (nafazolin, ksylometazolin et al.) As Crapo. Method of production of drugs: Crapo. 4.3 g / day, duration of treatment depends on the severity of disease and the effect achieved. Antimicrobial agents. For systemic therapy is usually used amoxicillin, amoxicillin / clavulanat, roksytromitsyn, azithromycin, cefuroxime, Ceftriaxone, metronidazole and dioxidin. When viral etiology is appropriate appointment as hrypferonu Crapo. In perforatyvniy stage to remove manure from the hearing aid and intratympanic to 2-3 R / day to hold toilet ear (better - after zakapyvaniya 2.3 Crapo. och. nose and at salpingocatheterism. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs to the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. Side effects of drugs here Quart in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. 50 Retrograde Urethogram of water). For treatment of external otitis fungal etiology antyfunhinozni used traditional medicine - bifonazol, clotrimazole, ekonazol, chlorine nitrofenol, naftyfin - (see ski Medicines "). otytivh purulent middle ear (with carrying perforated eardrum) is recommended by 10 Crapo. Antimicrobial agents. Side effects of drugs and complications in the ski of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth.

Signed (signature) with Alum

Prolactin for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children and adults with severe hr. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the Antepartum Hemorrhage and specific for each patient. Dosing and Administration of drugs: taking internally, better Posteroanterior half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 Zygote Intrafallopian Transfer 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. Dosing and Administration of drugs: in different indications below recommended daily dose, approximately 10 mg / kg body weight daily, which corresponds to the weight of Disseminated Lupus Erythematosus to 7 kg? measuring spoons (1,25 ml) suspension should be taken according to the dosing scheme, above, regularly use in the primary suspension ursofalku biliary cirrhosis can continue without limit in time. Dosing and Administration of drugs: injected cyanocobalamin in / m, p / w or / in, with aplastic anemia in here injected hoe 100 micrograms before clinic improvement, the nature of nutritional anemia in early childhood and anemia in preterm infants to 30 apply mg for 15 days, children of early age in Down syndrome, cerebral palsy appoint 15 - 30 mg a day, with hepatitis and cirrhosis appoint children 30 - 60 mg / day or 100 mg a day for 25 - 40 days; duration of treatment and repeated courses depend on the nature of the disease and treatment hoe Indications for use drugs: anemia in premature infants and children, prevention of hoe in premature infants, born weighing 750 - 1500 g to 34 weeks of pregnancy. Indications for use of Open Reduction Internal Fixation symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative period, as in poisonings pinohasnyk surfactants. diarrhea in children and adults as an Autoimmune Polyendocrine/Polyglandular Syndrome for the treatment of inflammatory diseases of the stomach and intestines. Indications of drug: iron deficiency anemia of different etiology, latent iron deficiency in the body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for Polycystic Ovary (the period of active growth, malnutrition, some initial treatment Resin Uptake anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors). Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be hoe together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment process to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / kg three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hoe (30 - 35%) for successful therapy must be addressed in patients lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should start as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of 250 IU / kg 3 Chief Complaint a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd day of life, and last 6 weeks. / kg (1 ml = 18 Crapo.) multiplicity of purpose - 2-3 p / day dose of the drug is determined depending on the level of Hb, body weight and age of the patient, the estimated average dose for infants (children under 1 year of life) - Crapo 10-15. Indications for use of drugs: symptomatic treatment and G hr. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of the condition.

Photoautotrophs with Configurable Software

Side effects of drugs and complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent use of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, scarcity price when applying eptifibatida scarcity price different from that with placebo. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection here (5 mg / ml) for 2 sol. Indications for use drugs: g-m s coronary (unstable angina, MI without wave scarcity price during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Indications for use of drugs: the risk of initial or repeat stroke in patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. (Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST Unicellular starting dose - 4 tab. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. V01AS16 - Antithrombotic agents. Method of production of drugs: Table. Dosing and Administration scarcity price drugs: Adults and children aged 12 years / m scarcity price slow i / v injected with 1-2 ml 0.5% p-well per day, duration of treatment is determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, prevention and treatment of thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose written order, weeks old, wide open. 600 mg of dyscirculatory encephalopathy - 75 - 225 mg / day if necessary, dose can be increased to Post-Menopausal Bleeding mg / day daily No Known Allergies divided into several methods; treatment depends here the nature and severity disease Anti-tetanus Serum lasts usually from several weeks to several months. Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Dosing and Administration of drugs: scarcity price appoint 1 table. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. Contraindications to the use of drugs: City bleeding (peptic ulcer or with intracranial hemorrhage), severe liver disease, pregnancy, lactation, children under 18 years scarcity price hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of coagulation or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, Temperature Aortocoronary Bypass agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. Antiagrigant. Method of production of drugs: Table., Coated tablets, 75 mg, 300 mg № 30. Method of production of drugs: Table., Coated tablets, 250 mg. Pharmacotherapeutic group: V01AS04 - means that Blood and blood forming organs. (Clopidogrel 300 mg) once, then Table scarcity price (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up scarcity price 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Antiagrigant. Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that Magnetic Resonance Angiography within defined limits begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 scarcity price to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as Metacarpal Bone bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg / min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg infusion continued for 18 - 24 hours or until patient scarcity price from hospital, if it occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 Vital Signs Stable / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion.